SWITZERLAND acquires ECRIN member status
ECRIN and the Swiss Clinical Trial Organisation (SCTO) are very pleased to announce that Switzerland officially became an ECRIN-ERIC Member country on 22 May 2023. Switzerland has been an ECRIN Observer country since December 2015, and its request for an ECRIN membership has been approved at the Assembly of Members meeting held in Warsaw on 22 May 2023. This membership came about as a result of the request by the Swiss Federal Council submitted on 13 April 2022. Switzerland is represented in the Assembly of Members by a delegate from the Swiss State Secretariat for Education, Research and Innovation (SERI). The Member status will enable Switzerland to have full access to ECRIN services.
Since Switzerland joined ECRIN in 2015, it has taken part in numerous ECRIN activities, counting more than twenty multinational clinical trials or infrastructure projects, including platform trials on COVID-19. With the transition of Switzerland to ECRIN Member, ECRIN’s network now counts 12 Member countries and 1 Observer country. The total reach of the ECRIN network covers over 361 million European citizens, with an average of 6.5 countries per trial.